03/10/2014 | Stela Vujosevic
Advances in understanding of the therapeutic mechanisms that underpin micropulse laser treatment suggest that protocols for treatment of diabetic macular edema should be integrated.
03/10/2014 | Florian Kretz
The Salzburg Reading Desk is one promising approach to standardizing visual assessments for multifocal intraocular lenses.
03/10/2014 | Mark Blecher
For the sake of our patients and our profession, we need to improve upon the nineteenth-century pictograms that are currently used for visual assessment.
03/10/2014 | Mark Hillen
Although baby boomers may be in a state of denial regarding their own aging, ophthalmologists know differently. In particular, four diseases of the ageing eye comprise a demographic and economic timebomb.
Aflibercept gets approved by NICE, STAAR’s Visian ICL with CentraFLOW gets approved in Japan, and rises and falls in Allergan and Alcon’s revenues.
Acucela prices its initial public offering on the Tokyo Stock Exchange at $162M.
Vision training can restore some of the sight lost to glaucoma.
The new method to produce stem cells has run into difficulties in the form of image irregularities and the failure of other labs to reproduce the findings.
Previous studies linked aspirin use with age-related macular degeneration, but new data suggest otherwise: aspirin is innocent of all charges.
If you’re aged over 68 years, then statins significantly reduce your risk of developing AMD; it has no impact on younger age groups.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: